Director sold ~$77K of Teradyne
Scheduled in advanceTraded Jun 2, 2026 · Filed Jun 4, 2026
A board member of Teradyne sold $62K of Teradyne shares. It was planned long ago, so it says very little.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$61,747
Shares × reported transaction price
34 days after results of Apr 29, 2026, 57 days before results of Jul 29, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $392.62 on Jun 2, 2026, 382% above its 52-week low and 6% below its high, after a 5% rise over the previous 30 trading days
52-week range $81.45 (Jun 3, 2025) to $418.08 (Apr 24, 2026), 92% of the way up, from 251 adjusted closes. 30 trading days earlier: $375.21 on Apr 20, 2026. Describes the past only, not a forecast
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | -6.3% | -2.5% | -3.7% |
| 30 days | -6.7% | -0.8% | -6.0% |
| 90 days | -16.0% | +1.1% | -17.1% |
Past results only. Not a forecast.
Director sold ~$77K of Teradyne
Scheduled in advanceCompensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.